Trial intelligence / Profile preview

Autologous Fat and SVF for Fistula-in-ano in Crohn's Disease

NCT02520843Phase 2Completed

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Oct 2015
Primary completion
Feb 2018
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose stromal vascular fraction in anal fistula, Crohn's disease, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Oct 2015; status: completed.

02

Drugs

autologous adipose stromal vascular fraction
03

Conditions

anal fistulaCrohn's disease

Beyond the preview

Go deeper on NCT02520843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02520843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call